Antiemetics

Peak Health and ImmunAG™ Announce Partnership with Medical Marijuana, Inc. To Sell First-Ever And Only Hops-Derived Cannabidiol (CBD) Product, ImmunAG™

Retrieved on: 
Tuesday, June 26, 2018

The product will be sold as Real Scientific Humulus Oil (RSHO-K) by Medical Marijuana, Inc.'s distribution subsidiary, HempMeds .

Key Points: 
  • The product will be sold as Real Scientific Humulus Oil (RSHO-K) by Medical Marijuana, Inc.'s distribution subsidiary, HempMeds .
  • Unlike CBD products derived from cannabis, which may contain trace amounts of Tetrahydrocannabinol (THC), ImmunAG contains no THC.
  • "We're very excited to partner with such an established and prestigious company as Medical Marijuana, Inc.," said Director of Peak Health, Dr. Bomi Joseph.
  • Peak Health does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).

North American Cannabis Holdings and Puration Take Next Step to Expand Reach Into $57 Billion Legal Cannabis Market

Retrieved on: 
Tuesday, June 26, 2018

North American Cannabis Holdings, Inc. (USOTC: USMJ) and Puration, Inc. (USOTC: PURA) today announced a substantial milestone in their recently disclosed strategy to expand their reach into the worldwide legal cannabis market expected to reach $57 billion in annual sales within the next ten years.

Key Points: 
  • North American Cannabis Holdings, Inc. (USOTC: USMJ) and Puration, Inc. (USOTC: PURA) today announced a substantial milestone in their recently disclosed strategy to expand their reach into the worldwide legal cannabis market expected to reach $57 billion in annual sales within the next ten years.
  • The strategic plan presentation is available in its entirety on the company website .
  • The milestone reached today entails both USMJ and PURA entering into respective agreements with two independently listed companies to facilitate the spinoff and dividends included in the overall strategic plan to expand their reach into the worldwide legal cannabis market.
  • The company's plan to release a letter to shareholders aftermarket this Friday, June 29th with more details on the spinoff milestone announced today.

Nelson Hardiman Partner Aaron Lachant Recognized for Leadership Role in L.A. Cannabis Law

Retrieved on: 
Monday, June 25, 2018

LOS ANGELES, June 25, 2018 /PRNewswire/ --The Los Angeles County Board of Supervisors commended Nelson Hardiman partner Aaron Lachant for his service on the Los Angeles County Advisory Working Group on Cannabis Regulation .

Key Points: 
  • LOS ANGELES, June 25, 2018 /PRNewswire/ --The Los Angeles County Board of Supervisors commended Nelson Hardiman partner Aaron Lachant for his service on the Los Angeles County Advisory Working Group on Cannabis Regulation .
  • "Nine years ago, we became the first firm in Southern California to take cannabis compliance seriously," says Lachant.
  • In many respects, Lachant has been credited as a linchpin in clarifying and developing standards for cannabis in Los Angeles.
  • With new opportunities anticipated as Los Angeles inches towards licensing and regulation, Lachant sees a bright future for local cannabis industry.

EVIO Labs Prepares for Increase in California Cannabis Testing Requests

Retrieved on: 
Wednesday, June 20, 2018

EVIO Labs Berkeley, previously C3 Labs, is well-positioned to meet the increase demand for analytical testing services for regulated cannabis and is prepared for these heightened regulations.

Key Points: 
  • EVIO Labs Berkeley, previously C3 Labs, is well-positioned to meet the increase demand for analytical testing services for regulated cannabis and is prepared for these heightened regulations.
  • Along with EVIO Labs Berkeley, EVIO has expanded their footprint in California.
  • EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry.
  • The Company's EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply.

CBD Infusion Into Growing Number of Products and Industries Skyrockets

Retrieved on: 
Tuesday, June 19, 2018

Such products as CBD balms for pain, CBD serums for fine lines, CBD moisturizers for acne... the list goes on.

Key Points: 
  • Such products as CBD balms for pain, CBD serums for fine lines, CBD moisturizers for acne... the list goes on.
  • Sales and promotions of CBD products (some combined with small amounts of THC) are exploding.
  • CBD, one of more than 100 cannabinoids found in marijuana, is made into tinctures, elixirs, balms and other products.
  • The products are touted for just about whatever ails you, and also for beauty, hygiene, stress reduction, and wellness.

Cannabis' Economic Impact to Expand With Emerging Markets

Retrieved on: 
Thursday, June 14, 2018

As for the economic impact that the new growing industry is set to have, the data predicts an estimated USD 28 Billion - USD 34 Billion economic impact in 2018.

Key Points: 
  • As for the economic impact that the new growing industry is set to have, the data predicts an estimated USD 28 Billion - USD 34 Billion economic impact in 2018.
  • Working alongside Revive, WeedMD will support the research, development and potential commercialization of CBD in the treatment of liver disease.
  • Additionally, Revive and WeedMD will identify opportunities for developing and commercializing medical cannabis products and therapies for potential collaboration in other treatments.
  • Intec Pharma Ltd. (NASDAQ: NETC) is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology.

Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients

Retrieved on: 
Thursday, June 14, 2018

ILANS represents an estimated 100,000 patients, with the majority of these patients being located in Colombia.

Key Points: 
  • ILANS represents an estimated 100,000 patients, with the majority of these patients being located in Colombia.
  • Alvaro Torres, Chief Executive Officer of Khiron, stated, "This exclusive strategic alliance with ILANS represents a significant increase in the size of the potential patient base for Khiron.
  • The alliance provides for research, technological product development, and evaluation and commercialization of products related to all aspects of medical cannabis.
  • Referral arrangements for treatment of patients with chronic pain, epilepsy, post-chemotherapy nausea, sleep disorders, Parkinson's disease, Tourette's syndrome, and multiple sclerosis.

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Import Permits for First-Ever THC-Free CBD Product in Argentina

Retrieved on: 
Wednesday, June 13, 2018

Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) has approved the product for import.

Key Points: 
  • Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) has approved the product for import.
  • "As a company of firsts, we're proud to offer the first THC-free CBD product in Argentina," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
  • "We're very excited to partner with HempMeds and distribute these high-quality CBD products in our country," said FLOS Innovation CEO Carlos Mendez.
  • In Argentina, CBD products are sold for compassionate use and must be prescribed by a licensed physician.

Kush Bottles, Inc. Closes $36,000,000 Registered Direct Offering

Retrieved on: 
Tuesday, June 12, 2018

The gross proceeds of the offering are approximately $36,000,000 before deducting placement agent fees and other estimated offering expenses.

Key Points: 
  • The gross proceeds of the offering are approximately $36,000,000 before deducting placement agent fees and other estimated offering expenses.
  • Kush Bottles' Chief Executive Officer, Nick Kovacevich, commented, "Kush Bottles has proven its ability to identify and monetize lucrative areas of the cannabis market.
  • We are pleased to secure this investment from institutional investors that share our vision for Kush Bottles and the cannabis industry."
  • Kush Bottles has no direct involvement with the cannabis plant or any products that contain tetrahydrocannabinol (commonly referred to as THC) or CBD.

Therapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette Syndrome

Retrieved on: 
Monday, June 11, 2018

Dr. Bloch, an Associate Professor at the Yale University Child Study Center, the investigator-initiator of the trial, and a member of the Company's scientific advisory board committee.

Key Points: 
  • Dr. Bloch, an Associate Professor at the Yale University Child Study Center, the investigator-initiator of the trial, and a member of the Company's scientific advisory board committee.
  • The study, suggesting that the proprietary cannabinoid combination THX-110 [which is a combination of dronabinol (-9-tetrahydracannabinol) and palmitoylethanolamide (PEA)] showed significantly improved symptoms over time in adult subjects with Tourette syndrome ( link to press release ).
  • The study was led together with James F. Leckman, M.D., Ph.D., of the Neison Harris Professor in the Child Study Center and Professor of Pediatrics Child Psychiatry at Yale University.
  • Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists.